RU2012100324A - METHOD FOR Predicting the severity of atopic dermatitis in children - Google Patents
METHOD FOR Predicting the severity of atopic dermatitis in children Download PDFInfo
- Publication number
- RU2012100324A RU2012100324A RU2012100324/14A RU2012100324A RU2012100324A RU 2012100324 A RU2012100324 A RU 2012100324A RU 2012100324/14 A RU2012100324/14 A RU 2012100324/14A RU 2012100324 A RU2012100324 A RU 2012100324A RU 2012100324 A RU2012100324 A RU 2012100324A
- Authority
- RU
- Russia
- Prior art keywords
- blood pressure
- severity
- predicting
- children
- blood
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Способ прогнозирования тяжести атопического дерматита у детей, включающий определение прогностических факторов, где учитывают клинические проявления: форма АД, распространенность АД и эозинофилы крови выраженное в процентах, где Y - тяжесть АД;X1 - форма АД, при этом:Х1=1 - экссудативная,Х1=2 - эритематозно-сквамозная,Х1=3 - эритематозно-сквамозная с лихенификацией,X1=4 - лихеноидная,Х2 - распространенность АД при этом:Х2=1 - ограниченный,Х2=2 - распространенный,Х2=3 - диффузный,Х3 - эозинофилы крови (в %), выражающийся в формуле:Y=-0,005(0,04)+0,034(0,02)×Х1+0,94(0,04)×Х2+0,023(0,004)×Х3.A method for predicting the severity of atopic dermatitis in children, including determining prognostic factors that take into account clinical manifestations: the form of blood pressure, the prevalence of blood pressure and blood eosinophils expressed as a percentage, where Y is the severity of blood pressure; X1 is the form of blood pressure, with: X1 = 1 - exudative, X1 = 2 - erythematous-squamous, X1 = 3 - erythematous-squamous with lichen, X1 = 4 - lichenoid, X2 - the prevalence of blood pressure in this case: X2 = 1 - limited, X2 = 2 - common, X2 = 3 - diffuse, X3 - blood eosinophils (in%), expressed in the formula: Y = -0.005 (0.04) +0.034 (0.02) × X1 + 0.94 (0.04) × X2 + 0.02 3 (0.004) × X3.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012100324/14A RU2012100324A (en) | 2012-01-10 | 2012-01-10 | METHOD FOR Predicting the severity of atopic dermatitis in children |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012100324/14A RU2012100324A (en) | 2012-01-10 | 2012-01-10 | METHOD FOR Predicting the severity of atopic dermatitis in children |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2012100324A true RU2012100324A (en) | 2013-07-20 |
Family
ID=48791460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012100324/14A RU2012100324A (en) | 2012-01-10 | 2012-01-10 | METHOD FOR Predicting the severity of atopic dermatitis in children |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2012100324A (en) |
-
2012
- 2012-01-10 RU RU2012100324/14A patent/RU2012100324A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201590993A1 (en) | HETERODIMERNY IMMUNOHLOBULINS | |
NZ606725A (en) | Methods for predicting anti-cancer response | |
MY162323A (en) | Anticoagulant antidotes | |
EP2802652A4 (en) | Clostridium histolyticum enzymes and methods for the use thereof | |
WO2011070297A3 (en) | Use of mirnas as biomarkers in glioma diagnosis | |
PH12014502436A1 (en) | In vitro method for the diagnosis and surveillance of cancer | |
PH12015501687A1 (en) | Novel binding proteins from pcsk9 | |
MX337203B (en) | Novel jnk inhibitor molecules. | |
EA201491804A1 (en) | GENES ENCODING PULP FOR CELLULASE FOR HYDROLYSIS OF RIPPING LIQUIDS ON THE BASIS OF GUARAMA GUM IN EXTREME BOTTOM CONDITIONS | |
WO2014209905A3 (en) | Methods and compositions for detecting and diagnosing diseases and conditions | |
BR112015009042A8 (en) | METHOD TO IDENTIFY A HETEROGENEOUS KIDNEY CELL POPULATION SUITABLE FOR IMPLANTATION AND/OR TRIGGING A REGENERATIVE RESPONSE | |
WO2012154908A3 (en) | Hairy cell leukemia biomarkers and methods of using same | |
PH12014501176A1 (en) | Anticoagulant reversal agents | |
WO2011119986A3 (en) | Methods for culturing and analyzing cells | |
MX358132B (en) | Thrombin solution and methods of use thereof. | |
MY164918A (en) | Board made from oil palm fiber and magnesium oxide and the manufacture process thereof | |
EA201491455A1 (en) | EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE | |
RU2012100324A (en) | METHOD FOR Predicting the severity of atopic dermatitis in children | |
RU2011127181A (en) | METHOD FOR INPUTING CONSUMABLE ELECTRODES INTO ALUMINUM AIR BATTERY | |
GB201204013D0 (en) | Method | |
RU2011144136A (en) | METHOD FOR QUANTITATIVE DETERMINATION OF IRON IONS | |
MD4285C1 (en) | Strain of Trichoderma koningii Oudemans fungi - producer of acid, neutral and alkaline proteases | |
GB201205444D0 (en) | Composition | |
UA107404C2 (en) | METHOD OF DETERMINING THE ABILITY OF LACTOBACILLUS TO PRODUCE HYDROGEN PEROXIS WITH THE USE OF BLOOD ERYTHROCYTES | |
RU2012109294A (en) | METHOD FOR PREDICTING PREGNANCY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20130813 |